Metabolomic Analysis of Histological Composition Variability of High-Grade Serous Ovarian Cancer Using 1H HR MAS NMR Spectroscopy
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252010903 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Agnieszka Skorupa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physics, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Metabolomics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center, Ministry of Science and Higher Education, National Science Center, Poland.
Abstract (Originalsprache)
In this work, the HR MAS NMR (high-resolution magic-angle spinning nuclear magnetic resonance) spectroscopy technique was combined with standard histological examinations to investigate the metabolic features of high-grade serous ovarian cancer (HGSOC) with a special focus on the relation between a metabolic profile and a cancer cell fraction. The studied group consisted of 44 patients with HGSOC and 18 patients with benign ovarian tumors. Normal ovarian tissue was also excised from 13 control patients. The metabolic profiles of 138 tissue specimens were acquired on a Bruker Avance III 400 MHz spectrometer. The NMR spectra of the HGSOC samples could be discriminated from those acquired from the non-transformed tissue and were shown to depend on tumor purity. The most important features that differentiate the samples with a high fraction of cancer cells from the samples containing mainly fibrotic stroma are the increased intensities in the spectral regions corresponding to phosphocholine/glycerophosphocholine, phosphoethanolamine/serine, threonine, uridine nucleotides and/or uridine diphosphate (UDP) nucleotide sugars. Higher levels of glutamine, glutamate, acetate, lysine, alanine, leucine and isoleucine were detected in the desmoplastic stroma within the HGSOC lesions compared to the stroma of benign tumors. The HR MAS NMR analysis of the metabolic composition of the epithelial and stromal compartments within HGSOC contributes to a better understanding of the disease’s biology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Physics, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.
- Department of Gynecology, Obstetrics and Oncological Gynecology, Faculty of Medicine in Katowice, Medical University of Silesia, 40-752 Katowice, Poland.
- Tumor Pathology Department, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.
ORCID-Profile: Agnieszka Skorupa, Mateusz Ciszek, Sławomir Pakuło, Bartosz Cichoń, Łukasz Boguszewicz
Förderung
- National Science Center
- Ministry of Science and Higher Education
- National Science Center, Poland
Zitieren
APA
Skorupa, A., Klimek, M., Ciszek, M., Pakuło, S., Cichoń, T., Cichoń, B., Boguszewicz, Ł., Witek, A., & Sokół, M. (2024). Metabolomic Analysis of Histological Composition Variability of High-Grade Serous Ovarian Cancer Using 1H HR MAS NMR Spectroscopy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252010903
Vancouver
Skorupa A, Klimek M, Ciszek M, Pakuło S, Cichoń T, Cichoń B, et al. Metabolomic Analysis of Histological Composition Variability of High-Grade Serous Ovarian Cancer Using 1H HR MAS NMR Spectroscopy. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252010903
BibTeX
@article{Skorupa2024,
author = {Skorupa, Agnieszka and Klimek, Mateusz and Ciszek, Mateusz and Pakuło, Sławomir and Cichoń, Tomasz and Cichoń, Bartosz and Boguszewicz, Łukasz and Witek, Andrzej and Sokół, Maria},
title = {Metabolomic Analysis of Histological Composition Variability of High-Grade Serous Ovarian Cancer Using 1H HR MAS NMR Spectroscopy},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252010903}
}
EUVIMED